RAF1 and cancer: The reduction of the dNTP pool and growth retardation could be seen in AGS and NCI-N87 cells after RRM1 siRNA treatment (Fig. 4A and 4B), which is consistent with the fact that the Ras/Raf/MAPK signaling pathway is related to cancer cell growth and metastasis [49].